ReviewEpilepsia2010

Mammalian target of rapamycin (mTOR) inhibition as a potential antiepileptogenic therapy: From tuberous sclerosis to common acquired epilepsies.

Michael WongPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.